Related Experiment Video
Updated: Mar 21, 2026

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
Published on: June 6, 2025
[MiR-181a Promotes Proliferation of Human Acute Myeloid Leukemia Cells by Targeting ATM]
Jia-Ye Hua1, Ying Feng1, Ying Pang1
1Department of Hematology, The Second Affiliated Hospital of Guangzhou Medical University, Guangzhou 510260, Guangdong Province, China.
Objective:
To investigate miR-181a function and regulation mechanism by identifying miR-181a target genes in acute myeloid leukemia (AML).
Methods:
The HL-60 cells of human AML was transfected by small molecular analog miR-181a, the cell proliferation was detected by CCK-8 method after electroporation in HL-60 cell lines. Target genes of miR-181a were predicted and analyzed by the bioinformatics software and database. Target genes were confirmed by HL-60 cell line and the patient leukemia cells.
Results:
Overexpressed miR-181a in HL-60 cell line significantly enhanced cell proliferation compared with that in control (P < 0.05). Dual luciferase reporter gene assay showed that miR-181a significantly suppressed the reporter gene activity containing ATM 3'-UTR by about 56.8% (P < 0.05), but it didn't suppress the reporter gene activity containing 3'-UTR ATM mutation. Western blot showed that miR-181a significantly downregulated the expression of ATM in human leukemia cells. It is also found that miR-181a was significantly increased in AML, which showed a negative correlation with ATM expression.
Conclusion:
miR-181a promotes cell proliferation in AML by regulating the tumor suppressor ATM, thus it plays the role as oncogene in pathogenesis of AML.
Insights
MicroRNA-181a (miR-181a) promotes acute myeloid leukemia (AML) cell proliferation by targeting the tumor suppressor ATM. This finding identifies miR-181a as an oncogene in AML pathogenesis.
Area of Science:
- Molecular Biology
- Oncology
- Gene Regulation
Background:
- Acute myeloid leukemia (AML) is a heterogeneous hematologic malignancy.
- MicroRNAs (miRNAs) play critical roles in cancer development and progression.
- Understanding miRNA function and regulatory mechanisms is crucial for AML treatment.
Purpose of the Study:
- To investigate the function of miR-181a in AML.
- To identify target genes regulated by miR-181a.
- To elucidate the regulatory mechanism of miR-181a in AML pathogenesis.
Main Methods:
- Transfection of HL-60 AML cells with miR-181a analog.
- Cell proliferation assays (CCK-8).
- Bioinformatic prediction and database analysis of miRNA targets.
- Dual luciferase reporter gene assays.
- Western blot analysis.
- Analysis of patient leukemia cells.
Main Results:
- Overexpression of miR-181a significantly enhanced HL-60 cell proliferation.
- miR-181a directly suppressed the activity of a reporter gene containing the ATM 3'-UTR.
- miR-181a significantly downregulated ATM expression in leukemia cells.
- miR-181a levels were significantly increased in AML patients and negatively correlated with ATM expression.
Conclusions:
- miR-181a acts as an oncogene in AML.
- miR-181a promotes cancer cell proliferation by targeting the tumor suppressor ATM.
- Regulation of ATM by miR-181a is a key mechanism in AML pathogenesis.
More Related Videos
13:10Detection and Visualization of DNA Damage-induced Protein Complexes in Suspension Cell Cultures Using the Proximity Ligation Assay
Published on: June 9, 2017
08:41Author Spotlight: Deciphering the Role of ATM in Ataxia-Telangiectasia and the Associated Cerebellar Degeneration
Published on: December 27, 2024
Related Concept Videos
Abnormal Proliferation
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
mTOR Signaling and Cancer Progression
The mTOR pathway or the...